Skip to main content
Figure 1 | Cardiovascular Diabetology

Figure 1

From: Therapeutic potential of N-acetylcysteine as an antiplatelet agent in patients with type-2 diabetes

Figure 1

Therapeutic potential of in vitro additions of NAC to reduce platelet aggregability in whole blood from patients with type-2 diabetes. Inhibition of (A) thrombin- (0.125-1.0 U/ml) and (B) ADP (10 μmol/l)-induced platelet aggregation, by NAC (10-100 μmol/l; 2 h, 37°C), (n = 13 for both). Black circles = vehicle control; white triangles = 10 μmol/l NAC; black squares = 30 μmol/l NAC; white diamonds = 100 μmol/l NAC. Data are expressed as mean ± sem; statistical analysis was performed by two-way ANOVA with Bonferroni's post hoc correction for multiple testing (treatment vs control). **P < 0.01, ***P < 0.001.

Back to article page